UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as COO Pharmaceutical Investing
Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline Pharmaceutical Investing
Teligent Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented) Pharmaceutical Investing
Intercept Pharmaceuticals Reports Full Year and Fourth Quarter 2017 Financial Results Pharmaceutical Investing
